• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

INSM:US

13.4100 USD 0.8800 7.02%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Insmed Inc (INSM)

Open: 12.4900 Day's Range: 12.2501 - 13.5700 Volume: 1,547,901
Previous Close: 12.5300 52wk Range: 7.1500 - 22.2900 1-Yr Rtn: +79.28%

Stock Chart for INSM

No chart data available.
  • INSM:US 13.4100
  • 1D
  • 1M
  • 1Y
12.5300
Interactive INSM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5835
Est. EPS (USD) (12/2014) -1.7160
Est. PEG Ratio -
Market Cap (M USD) 526.60
Shares Outstanding (M) 39.27
30 Day Average Volume 1,147,934
Price/Book (mrq) 3.6619
Price/Sale (ttm) 37.0279
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSM

Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.

William H Lewis "Will"President/CEOAndrew T DrechslerChief Financial Officer
Matthew PaulsChief Commercial OfficerRenu GuptaExec VP:Dev/Chief Medical Ofcr
More Company Profile & Key Executives for INSM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil